(Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | (Q6)Dec 31, 2020 | (FY)Jun 30, 2020 | (Q6)Dec 31, 2019 | (FY)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -25.32%174K | -91.46%233K | -96.42%233K | -75.29%2.73M | 566.09%6.5M | 236.91%11.04M | -62.10%976K | -15.78%3.28M | 16.83%2.58M | -24.09%3.89M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 23.35%-174K | ---227K | ---227K | ---- | ---- | 91.10%-13K | 48.00%-13K | ---146K | ---25K | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---664K | ---763K | ---- | ---- | ---- |
Impairment and provisions: | -91.66%268K | 53.34%3.21M | 2,498.51%3.21M | 105.09%2.1M | -152.55%-134K | 0.00%1.02M | 183.33%255K | 590.54%1.02M | 119.51%90K | -1.99%148K |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | 28.67%-102K | ---- | ---143K | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | -91.66%268K | 882.87%3.21M | 2,498.51%3.21M | -71.93%327K | -152.14%-134K | 47.84%1.17M | 307.94%257K | 432.43%788K | 600.00%63K | 102.74%148K |
-Impairment of goodwill | ---- | ---- | ---- | --1.87M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | -107.41%-2K | --234K | -15.63%27K | ---- |
Revaluation surplus: | --0 | --0 | --0 | --0 | --0 | ---1.43M | --0 | --0 | --0 | --0 |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---1.43M | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---1K | --0 |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1K | ---- |
Depreciation and amortization: | -77.68%244K | -10.70%1.09M | 80.66%1.09M | 55.53%1.22M | 172.52%605K | 93.84%787K | 174.07%222K | 224.80%406K | 26.56%81K | -6.02%125K |
-Depreciation | -79.09%216K | -10.87%1.03M | 80.59%1.03M | 53.51%1.16M | 164.81%572K | 85.96%755K | 166.67%216K | 224.80%406K | 26.56%81K | -6.02%125K |
-Amortization of intangible assets | -53.33%28K | -7.69%60K | 81.82%60K | 103.13%65K | 450.00%33K | --32K | --6K | ---- | ---- | ---- |
Financial expense | -68.33%70K | 62.50%221K | 513.89%221K | 102.99%136K | 24.14%36K | 1.52%67K | 3.57%29K | 34.69%66K | 33.33%28K | -42.35%49K |
Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | -68.97%-49K | 1,225.00%53K | -383.33%-29K | 233.33%4K | -300.00%-6K |
Special items | ---- | ---- | ---- | ---- | ---2K | -71.43%4K | ---- | -77.42%14K | ---- | --62K |
Operating profit before the change of operating capital | -87.16%582K | -26.69%4.53M | -35.28%4.53M | -42.55%6.19M | 823.06%7.01M | 133.46%10.77M | -72.42%759K | 7.99%4.61M | 18.26%2.75M | -22.35%4.27M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | 56.64%-1.88M | 49.64%-4.35M | -367.71%-4.35M | -7.85%-8.63M | 86.80%-929K | -2,767.38%-8M | -140,840.00%-7.04M | 71.56%-279K | -99.17%5K | -103.53%-981K |
Accounts payable increase (decrease) | 138.79%1.04M | -184.35%-2.68M | -1,631.61%-2.68M | -67.99%3.18M | -102.00%-155K | 398.11%9.94M | 394.18%7.73M | -323.68%-3.34M | -666.18%-2.63M | -13.31%1.49M |
Cash from business operations | 101.23%43K | -471.61%-3.51M | -164.74%-3.51M | -92.36%944K | 55.90%5.42M | 1,540.50%12.35M | 810.84%3.48M | -83.05%753K | -121.41%-489K | -27.58%4.44M |
Other taxs | 83.09%-82K | 76.46%-485K | -410.53%-485K | -24.32%-2.06M | 88.13%-95K | -46.64%-1.66M | -13.48%-800K | 32.78%-1.13M | 22.44%-705K | -615.32%-1.68M |
Interest paid - operating | ---18K | ---- | ---- | ---- | ---- | ---- | ---2K | ---8K | ---- | ---- |
Special items of business | 130.01%304K | -594.15%-1.01M | -101.39%-1.01M | 157.91%205K | -124.86%-503K | -45.08%-354K | 427.35%2.02M | 27.81%-244K | -104.64%-618K | 43.95%-338K |
Net cash from operations | 98.57%-57K | -257.80%-3.99M | -175.00%-3.99M | -110.43%-1.12M | 99.10%5.32M | 2,878.18%10.7M | 323.95%2.67M | -113.94%-385K | -186.84%-1.19M | -53.20%2.76M |
Cash flow from investment activities | ||||||||||
Interest received - investment | --59K | --227K | ---- | ---- | ---- | -91.10%13K | -48.00%13K | --146K | --25K | ---- |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%3K | --2K | --1K | ---- |
Purchase of fixed assets | ---- | -70.21%-80K | -158.06%-80K | 79.02%-47K | 89.01%-31K | -206.85%-224K | 94.18%-282K | -356.25%-73K | -43,945.45%-4.85M | 74.19%-16K |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---21K | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---14.88M | ---9.97M | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | ---- | -4,578.69%-8.56M | 60.30%-2.86M | ---183K | -1,360.24%-7.2M | ---- | ---493K |
Other items in the investment business | -100.23%-18K | --7.69M | --7.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Adjustment items of investment business | -49.34%115K | ---- | --227K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | -98.01%156K | 16,778.72%7.84M | 191.23%7.84M | 99.74%-47K | 17.53%-8.59M | -152.27%-17.97M | -116.23%-10.42M | -1,299.61%-7.12M | -43,709.09%-4.82M | 55.70%-509K |
Net cash before financing | -97.43%99K | 430.70%3.85M | 217.65%3.85M | 84.02%-1.16M | 57.80%-3.27M | 3.10%-7.28M | -28.82%-7.75M | -433.44%-7.51M | -540.84%-6.01M | -52.59%2.25M |
Cash flow from financing activities | ||||||||||
New borrowing | -100.53%-4K | 80.76%761K | --761K | -26.27%421K | ---- | --571K | ---- | ---- | ---- | ---- |
Refund | 38.70%-396K | -378.52%-646K | -1.10%-646K | -5.47%-135K | -947.54%-639K | -6.67%-128K | 0.00%-61K | 0.00%-120K | 1.61%-61K | -13.21%-120K |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 224.51%17.25M | --17.25M | --5.32M |
Interest paid - financing | 73.06%-52K | -112.09%-193K | -436.11%-193K | -35.82%-91K | -33.33%-36K | -15.52%-67K | 0.00%-27K | -18.37%-58K | -28.57%-27K | 42.35%-49K |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -476.62%-1.33M |
Other items of the financing business | 92.89%-68K | 5.15%-957K | -107.14%-957K | -158.22%-1.01M | -263.78%-462K | 776.95%1.73M | -1,311.11%-127K | ---256K | ---9K | ---- |
Net cash from financing operations | 49.76%-520K | -27.15%-1.04M | 8.97%-1.04M | -138.60%-814K | -428.84%-1.14M | -87.46%2.11M | -101.25%-215K | 340.81%16.82M | 6,204.63%17.15M | 213.47%3.82M |
Effect of rate | -14.78%-435K | -12,733.33%-379K | -243.02%-379K | -99.07%3K | 5,200.00%265K | 1,013.79%323K | --5K | 1,066.67%29K | ---- | -175.00%-3K |
Net Cash | -114.98%-421K | 242.19%2.81M | 163.80%2.81M | 61.74%-1.98M | 44.66%-4.41M | -155.51%-5.17M | -171.46%-7.96M | 53.42%9.31M | 928.72%11.14M | 337.10%6.07M |
Begining period cash | 19.76%14.74M | -13.82%12.31M | -13.82%12.31M | -25.33%14.28M | -25.33%14.28M | 95.39%19.13M | 95.39%19.13M | 162.84%9.79M | 162.84%9.79M | 59.69%3.72M |
Cash at the end | -5.81%13.88M | 19.76%14.74M | 45.36%14.74M | -13.82%12.31M | -9.21%10.14M | -25.33%14.28M | -46.63%11.17M | 95.39%19.13M | 335.48%20.93M | 162.84%9.79M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Deloitte & Touche LLP | -- | Deloitte & Touche LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data